Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias

被引：1
|
作者：
Montastruc, Francois [1 ,2 ,3 ]
de Canecaude, Claire [1 ,2 ]
机构：
[1] Toulouse Univ Hosp CHU, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, Toulouse, France
[2] Toulouse Univ Hosp, Ctr Invest Clin 1436, Team PEPSS Pharmacol Populat cohorteS & biobanqueS, Toulouse, France
[3] Toulouse Univ Hosp, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, 37 Allees Jules Guesde, F-31000 Toulouse, France
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 76卷 / 11期
关键词：
D O I：
10.1093/cid/ciad089
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2044 / 2045
页数：2
相关论文
共 50 条
  • [1] Cardiac and vascular serious adverse events following tixagevimab-cilgavimab
    Maselkar, Sheetal
    Kiazand, Alexandre
    Templeton, Alison
    Montgomery, Hugh
    Esser, Mark T.
    LANCET RESPIRATORY MEDICINE, 2023, 11 (01): : E7 - E8
  • [2] Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population
    Shaikh, Suhail A.
    Morado, Faiza
    Kawewat-Ho, Pnada
    Cartus, Rachel
    Davoudi, Roland
    Forrester, Kevin
    Azizian, Krist
    Blodget, Emily
    Maw, Thin Thin
    Nanda, Neha
    CLINICAL TRANSPLANTATION, 2022, 36 (06)
  • [3] Efficacy of Tixagevimab-Cilgavimab as Immunoprophylaxis in Patients With Hematologic Cancer
    Salvini, Marco
    Grossi, Paolo Antonio
    Cacioppo, Alessandro
    Merli, Michele
    Pellegrini, Giacomo
    Brociner, Marco
    Passamonti, Francesco
    JAMA ONCOLOGY, 2024, 10 (03) : 405 - 407
  • [4] Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
    Benotmane, Ilies
    Olagne, Jerome
    Gautier-Vargas, Gabriela
    Cognard, Noelle
    Heibel, Francoise
    Braun-Parvez, Laura
    Keller, Nicolas
    Martzloff, Jonas
    Perrin, Peggy
    Pszczolinski, Romain
    Moulin, Bruno
    Fafi-Kremer, Samira
    Caillard, Sophie
    TRANSPLANTATION, 2023, 107 (08) : E215 - E218
  • [5] Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019
    Montastruc, Francois
    Lafaurie, Margaux
    Flumian, Clara
    de Canecaude, Claire
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) : 543e1 - 543e3
  • [6] Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
    Vellas, Camille
    Kamar, Nassim
    Izopet, Jacques
    JOURNAL OF INFECTION, 2022, 85 (05) : E162 - E163
  • [7] Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence
    Altieri, Manuela
    Melisi, Rosario Domenico
    Conte, Miriana
    Capuano, Rocco
    Donnarumma, Giovanna
    Grimaldi, Elena
    Coppola, Nicola
    De Pascalis, Stefania
    Risi, Mario
    d'Ambrosio, Alessandro
    Bisecco, Alvino
    Gallo, Antonio
    NEUROLOGICAL SCIENCES, 2023, 44 (11) : 4107 - 4110
  • [8] Real-oWorld Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation
    Yan, Vincent K. C.
    Yu, Yang
    Wan, Eric Y. F.
    Wong, Ian Chi Kei
    Chan, Esther W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 202 - 202
  • [9] Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19
    Levin, Myron J.
    Ustianowski, Andrew
    De Wit, Stephane
    Launay, Odile
    Avila, Miles
    Templeton, Alison
    Yuan, Yuan
    Seegobin, Seth
    Ellery, Adam
    Levinson, Dennis J.
    Ambery, Philip
    Arends, Rosalinda H.
    Beavon, Rohini
    Dey, Kanika
    Garbes, Pedro
    Kelly, Elizabeth J.
    Koh, Gavin C. K. W.
    Near, Karen A.
    Padilla, Kelly W.
    Psachoulia, Konstantina
    Sharbaugh, Audrey
    Streicher, Katie
    Pangalos, Menelas N.
    Esser, Mark T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (23): : 2188 - 2200
  • [10] Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial
    Holland, Thomas L.
    Ginde, Adit A.
    Paredes, Roger
    Murray, Thomas A.
    Engen, Nicole
    Grandits, Greg
    Vekstein, Andrew
    Ivey, Noel
    Mourad, Ahmad
    Sandkovsky, Uriel
    Gottlieb, Robert L.
    Berhe, Mezgebe
    Jain, Mamta K.
    Marines-Price, Rubria
    Agbor, Barbine Tchamba Agbor
    Mateu, Lourdes
    Espana-Cueto, Sergio
    Llados, Gemma
    Mylonakis, Eleftherios
    Rogers, Ralph
    Shehadeh, Fadi
    Filbin, Michael R.
    Hibbert, Kathryn A.
    Kim, Kami
    Tran, Thanh
    Morris, Peter E.
    Cassity, Evan P.
    Trautner, Barbara
    Pandit, Lavannya M.
    Knowlton, Kirk U.
    Leither, Lindsay
    Matthay, Michael A.
    Rogers, Angela J.
    Drake, Wonder
    Jones, Beatrice
    Poulakou, Garyfallia
    Syrigos, Konstantinos N.
    Fernandez-Cruz, Eduardo
    Di Natale, Marisa
    Almasri, Eyad
    Balerdi-Sarasola, Leire
    Bhagani, Sanjay R.
    Boyle, Katherine L.
    Casey, Jonathan D.
    Chen, Peter
    Douin, David J.
    Files, D. Clark
    Gunthard, Huldrych F.
    Hite, R. Duncan
    Hyzy, Robert C.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (10): : 972 - 984
12345